Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Jan 27;2(2):168–174. doi: 10.1158/1940-6207.CAPR-08-0107

Figure 4.

Figure 4

The effect of bexarotene on the tumor-producing capabilities of p53 null mammary epithelium in virgin mice. The high dose of bexarotene (Inline graphic) but not the low does (Inline graphic) delayed tumorigenesis compared to control mice (Inline graphic).